News
Landmark review of glaucoma treatment and research published by Moorfields-led team
Four world-leading experts, including Hari Jayaram and Gus Gazzard from Moorfields, have combined their knowledge with the findings from over 150 peer-reviewed study publications to produce a landmark paper published in the Lancet.
Welcome back to the Association of Ophthalmic Nurses and Technicians
The Association of Ophthalmic Nurses and Technicians (AONT) is an independent professional network for ophthalmic nurses and technicians created with a vision to support and enhance care through greater awareness of new roles, resources, and education.
Winner Announcement - Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’
Dr Sancy Low, Consultant Ophthalmic Surgeon at Guy’s and St Thomas’ NHS Foundation Trust, wins the Glaucoma UK ‘Excellence in Glaucoma Care Award 2023’.
First UK Direct Selective Laser Trabeculoplasty (DSLT) device placed at Moorfields
Following an internationally successful Randomised Controlled Trial (RCT) comparing the Direct Selective Laser Trabeculoplasty (DSLT) with standard SLT, the first ever commercial device in the UK, the ‘Eagle’, has been installed and is in use at Moorfields Eye Hospital in London.
New Opportunity for Glaucoma Researchers: Apply Now for Glaucoma UK's Open Call Research Award
Glaucoma UK announces the Open Call Research Award 2023, offering up to £50,000 in funding for glaucoma-related research.
Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.
Make eye drops a part of your Ramadan routine
Glaucoma UK, the Muslim Council of Britain (MCB), and the British Islamic Medical Association (BIMA) are encouraging Muslims with glaucoma to continue using their medication as prescribed during the holy month to prevent irreversible sight loss.
